Unique immune signatures predict potential cardiometabolic risk in severe COVID-19 patients and COVID-19 recovered individualsNamal P. M. Liyanage, Nicholas Funderburg, Janelle Gabriel et al.|The Journal of Immunology|2021Cited by 1
SARS-CoV-2 mediated monocytes dysregulation may contribute to increase risk of cardiovascular risk in severe COVID-19 patientsManuja Gunasena, Namal P. M. Liyanage, Yasasvi Wijewantha et al.|The Journal of Immunology|2021Cited by 0